UTILIZATION OF A ONE-DIMENSIONAL SCORE FOR SURVEYING CHEMICAL-INDUCED CHANGES IN EXPRESSION LEVELS OF MULTIPLE BIOMARKER GENE SETS USING A LARGE-SCALE TOXICOGENOMICS DATABASE
スポンサーリンク
概要
- 論文の詳細を見る
A large-scale toxicogenomcis database has now been constructed in the Toxicogenomics Project in Japan (TGP). To facilitate the analytical procedures for such large-scale microarray data, we developed a simple one-dimensional score, named TGP1 which expresses the trend of the changes in expression of biomarker genes as a whole. To evaluate the usefulness of the TGP1 score, microarray data of rat liver and rat hepatocytes deposited in the TGP database were scored for three biomarker gene sets, i.e., carcinogenesis-related, PPARα-regulated and glutathione depletion-related gene sets. The TGP1 scoring system gave reasonable results, i.e., the scores for carcinogenesis-related genes were high in omepra-zole-, chlorpromazine-, hexachlorobenzene-, sulfasalazine- and Wy-14,643-treated rat livers, that for PPARα-regulated genes were high in clofibrate-, Wy-14,643-, gemfibrozil-, benzbromarone- and aspirin-treated rat livers as well as rat hepatocytes, and for glutathione deficiency-related genes were high in ome-prazole-, bromobenzene-, acetaminophen- and coumarin-treated rat liver. We concluded that the TGP1 score is useful for surveying the expression changes in multiple biomarker gene sets for a large-scale toxicogenomics database, which would reduce the time of doing conventional multivariate statistical analysis. In addition, the TGP1 score can be applied to screening of compatible biomarker gene sets between rat liver and rat hepatocytes, like PPARα-regulated gene sets, which will allow us to develop an appropriate in vitro system for drug safety assessment in vivo.
- 日本トキシコロジー学会の論文
- 2006-12-15
著者
-
NAGAO Taku
National Institute of Health Sciences
-
Nagao Taku
Food Safety Commission Of Japan
-
Nagao Taku
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Nagao Taku
Laboratory Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences The University
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Kiyosawa Naoki
Toxicogenomics Project National Inst. Of Biomedical Innovation
-
Kiyosawa Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Miwa Satoko
Exploratory Toxicology & Dmpk Research Laboratories Tanabe Seiyaku Co. Ltd.
-
MIZUKAWA Yumiko
Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liber
-
MIYAGISHIMA Toshikazu
Toxicogenomics Project, National Institute of Biomedical Innovation
-
URUSHIDANI Tetsuro
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Shimizu Toshinobu
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Suzuki Takamasa
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation:department Of Pathophysiology Dos
-
Urushidani Tetsuro
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Miyagishima Toshikazu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Uehara Takeki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Shiwaku Kouji
Toxicogenomics Project National Institute Of Biomedical Innovation
-
OMURA Ko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
HIRODE Mitsuhiro
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Omura Ko
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Mizukawa Yumiko
Toxicogenomics Project National Institute Of Biomedical Innovation:department Of Pathophysiology Fac
-
Shimizu Toshinobu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nagao Taku
National Institute Of Health Sci.
-
Hirode Mitsuhiro
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Ono Atsushi
Toxicogenomics Informatics Project, National Institute of Biomedical Innovation
関連論文
- Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR)
- CHARACTERIZATION OF RESISTANCE TO BROMOBENZENE-INDUCED HEPATOTOXICITY BY MICROARRAY
- RESISTANCE TO THE SKELETAL MUSCLE INJURY EXPRESSED BY REPEATED TREATMENT WITH COMPOUND A THAT HAS HMG-CoA REDUCTASE INHIBITORY ACTIVITY
- P7-41 Skeletal muscle injury caused by compound A completely recovers in spite of further treatment?(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Involvement of Drug Transporters in the Acquired Resistance to Bromobenzene-induced Hepatotoxicity (LIVER/DIGESTIVE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Enigma of oxidative stress in benzene induced hematotoxicity answered by thioredoxin-overexpression mouse(Blood, Biomarker, Proceedings of the 32nd Annual Meeting)
- "C-1 Reproductive and Developmental Toxicity Studies of Toluene. : II. Effects of inhalation exposure on fertility in rats.
- Reproductive and Developmental Toxicity Studies of Toluene.I.Teratogenicity Study of Inhalation Exposure in Pregnant Rats.
- REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDIES OF TOLUENE I. TERATOGENICITY STUDY OF INHALATION EXPOSURE IN PREGNANT RATS
- A SURVEY OF THE VALUES OF CLINICAL CHEMISTRY PARAMETERS OBTAINED FOR A COMMON RAT BLOOD SAMPLE IN NINETY-EIGHT JAPANESE LABORATORIES